Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In 2023, the company finalized ...

Investors are growing skeptical that Chinese developer stocks will stage a rebound this year, as Beijing’s reluctance to unleash sweeping stimulus deepens pessimism about the sector.

With the TSX at a new record high, investors are wondering which top Canadian stocks might still be attractive to buy for a ...

Hindustan Zinc looks like a textbook commodity winner. It enjoys strong margins, rising demand and world-class reserves. Yet ...

Apple has fallen behind in the AI arms race. As earnings season approaches, investors should review their portfolios and ...

The growing demand for AI computing power has propelled both CoreWeave and Nvidia's businesses to new heights. Nvidia ...

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

Inflation accelerated in June, with the latest data showing that consumer prices rose 2.4% year-over-year. Shedding light on ...

SPDR Portfolio S&P 500 ETF offers lowest expense ratio, strong long-term returns, & excellent liquidity for retail investors.

Learn more about whether Freshworks Inc. or Pagaya Technologies Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

These four dividend stocks are ideal choices for growth and income investors seeking reliable passive income with some growth potential.

Blue-chip stocks are publicly traded shares of well-established, mature, financially stable companies that have a long-term history of consistent positive performance. Most blue-chip stocks are ...